CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$30.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$55M
2
+$52.9M
3
+$42.4M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$39.1M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$17.7M

Top Sells

1
+$46.7M
2
+$45.1M
3
+$42.8M
4
VTYX icon
Ventyx Biosciences
VTYX
+$35.4M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$20.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$16.3M 1.07%
4,116,949
27
$15.2M 1%
110,000
-90,000
28
$15.1M 0.99%
1,821,739
-150,000
29
$14.9M 0.98%
868,550
30
$14.5M 0.96%
80,000
-30,000
31
$13.7M 0.9%
+576,373
32
$13.3M 0.88%
1,000,000
-650,000
33
$12.2M 0.81%
+325,000
34
$11.9M 0.79%
+81,250
35
$11.1M 0.73%
+1,271,429
36
$10.7M 0.7%
3,082,000
+1,000,000
37
$10.4M 0.69%
296,000
38
$10.3M 0.68%
275,000
-50,000
39
$9.44M 0.62%
2,353,141
+234,858
40
$9.06M 0.6%
1,087,807
41
$9.03M 0.59%
734,350
42
$8.33M 0.55%
+4,250,000
43
$7.55M 0.5%
700,000
-200,000
44
$6.58M 0.43%
816,460
45
$6.04M 0.4%
616,786
46
$5.18M 0.34%
1,547,181
47
$5.05M 0.33%
350,000
48
$4.81M 0.32%
+1,250,000
49
$4.81M 0.32%
350,000
50
$4.74M 0.31%
593,043
1
2
3 4